meta|Evidence - COVID-19
Member of the meta|Evidence galaxy
Treament | Trials | |||||
---|---|---|---|---|---|---|
Statistically conclusive or suggested result | Inconclusive results | Uncertain results | Safety results | |||
|
1 / 2 | none | inconclusive results for: death D28; hospitalization or death; hospitalization; viral clearance ; viral clearance by day 7; emergent treatment-resistant variants | - | - | |
|
2 | none | inconclusive results for: deaths; hospitalization; serious adverse events | suggested 45 % decrease in adverse events but the degree if certainty is unassessable | - | |
|
2 / 4 | inconclusive results for: viral clearance ; viral clearance by day 7; emergent treatment-resistant variants | suggested 95 % decrease in deaths but the degree if certainty is unassessable | - | ||
|
1 | none | inconclusive results for: death D28; deaths; adverse events | suggested 76 % decrease in clinical deterioration but the degree if certainty is unassessable suggested 80 % decrease in hospitalization but the degree if certainty is unassessable | - |
Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant
149
treatments |
718
studies with results |
1743
studies screend |
1629
references |
This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.
- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy -